Package 68071-3624-3

{"route": ["ORAL"], "spl_id": "1ac7a6de-4617-c142-e063-6394a90a4d71", "openfda": {"upc": ["0368071362435"], "unii": ["G447S0T1VC"], "rxcui": ["313564"], "spl_set_id": ["1ac7a13e-3f30-e140-e063-6394a90aa09d"], "manufacturer_name": ["NuCare Pharmaceuticals,Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (68071-3624-3)", "package_ndc": "68071-3624-3", "marketing_start_date": "20240613"}], "brand_name": "Valacyclovir", "product_id": "68071-3624_1ac7a6de-4617-c142-e063-6394a90a4d71", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68071-3624", "generic_name": "Valacyclovir", "labeler_name": "NuCare Pharmaceuticals,Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1000 mg/1"}], "application_number": "ANDA209553", "marketing_category": "ANDA", "marketing_start_date": "20230214", "listing_expiration_date": "20261231"}